Veolity: AI-enabled clinical solutions for lung cancer diagnostics at WCLC 2022

The World Conference on Lung Cancer 2022 (WCLC) takes place from August 6-9, 2022 in Vienna, Austria. At this world's largest international meeting of experts in the field of lung cancer and thoracic oncology MeVis presents its clinical solutions focusing on lung cancer diagnostics.


  • Veolity LungCAD - the PACS-integrated nodule detection AI. Veolity LungCAD provides deep learning based detection support for pulmonary nodules, complex follow-up comparisons including valuable automatic segmentation with volumetric quantification.
  • Veolity LungRead - the all-in-one chest CT reading solution. Veolity LungRead is our dedicated software package for efficient and effective reading of chest CT scans for both lung cancer screening and incidental nodule management as well. Physicians benefit from deep learning based CAD, volumetric nodule measurements, automatic growth assessment, and guideline compliant reporting, which save reading time compared to a standard PACS viewer.

Meet MeVis at WCLC 2022 in Vienna, Austria:

Hall B1, booth no. 405

Messe Wien Exhibition & Congress Center
Messeplatz 1
1021 Vienna